BACKGROUND: Salivary gland aspiration cytology is useful in the preoperative management of patients but remains challenging, because of the extensive morphologic overlap of some tumors limits the ability to always determine the presence of malignancy. In response to this challenge, there has been increasing drive to develop a risk-based categorization scheme for salivary gland aspirates. Herein, the authors examine the interobserver variability of 1 such pattern and riskbased system. METHODS: Select smears and cell-block sections of 50 salivary gland aspirates from 2 large academic centers were digitally imaged. These scanned slides were independently and blindly reviewed by 4 cytopathologists, and each aspirate was assigned to 1 of the proposed pattern-based categories if it was considered neoplastic by the observer.
INTRODUCTION
Aspiration cytology of salivary gland tumors is useful as a preoperative tool for selecting patients who are in need of surgical excision and for determining the extent of surgery required for such patients. Salivary gland fine-needle aspiration (FNA) is a cost-effective triage tool and can help reduce the number patients who undergo surgery. 1 In a systematic review and meta-analysis of the diagnostic accuracy of FNA for parotid gland lesions, Schmidt et al estimated 96% sensitivity and 98% specificity in the distinction of neoplastic versus non-neoplastic tumors. 2 The distinction of benign versus malignant in their review article had an estimated lower sensitivity of 80% and 97% specificity. A more recent meta-analysis produced similar estimates for the ability of parotid FNA to differentiate benign versus malignant (sensitivity 78%; specificity 98%). 3 Although both of those studies had good sensitivity and specificity, there is considerable heterogeneity among individual studies, ranging from 0% to 100% for sensitivity and from 67% to 100% for specificity. 2, 3 Despite the good performance of salivary gland FNA reported in the literature, many challenges remain in this area. The primary challenge is the difficulty experienced in specifically diagnosing tumor entities, which can be attributed to the extensive morphologic overlap of some salivary gland tumors. This morphologic overlap is perhaps most prominent in the area of basaloid neoplasms and was exemplified in a recent College of American Pathologists (CAP) survey focusing on the cytologic recognition of adenoid cystic carcinoma (AdCC). 4 That survey concluded that the accurate identification of AdCC on cytologic samples is a problematic area, with a false-negative rate for malignancy of 36.4%. Misinterpretation of aspirates from AdCC as pleomorphic adenoma (PA) or monomorphic adenoma was the most common reason for false-negative results.
There are similar challenges in the diagnosis of oncocytoid neoplasms, and this is best demonstrated in the significant overlap that can be observe in aspirates of lowgrade mucoepidermoid carcinoma (MEC) and Warthin tumor (WT) with mucinous metaplasia. Because the diagnosis of WT should prompt simple excision or even just observation, the misdiagnosis of MEC as WT on aspiration cytology could result in disease progression for some patients. Similarly, the diagnosis of acinic cell carcinoma (AciCC) is also a potential source of false-negative cytology because of the frequent bland appearance of tumor cells, which can mimic non-neoplastic salivary acini. 5 The recent description of secretory carcinoma of salivary glands also highlights the morphologic overlap with AciCC. 6, 7 Although studies examining specific morphologic features are available in the literature regarding the distinction of some salivary gland tumors from morphologic mimics, there has been a more recent trend toward developing a risk-stratification approach to classify salivary gland aspirates to help guide management. In a retrospective, multiinstitutional, international study, the separation of salivary gland aspirates into primary categories of neoplasm, atypical, suspicious for malignancy, and malignant resulted in stratification according to the risk of malignancy (ROM) (6%, 53%, 79%, and 100%, respectively). 8 More recently, it was demonstrated that the designation of salivary aspirates as suspicious for malignancy had a similarly high ROM (84.2%), with no statistically significant difference between 5 international tertiary medical centers. 9 In contrast, another abstract by the same authors reported a wide range in the ROM for salivary gland aspirates designated as atypical (mean ROM, 62.99%; range, 0%-73.08%).
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The Milan System for Reporting Salivary Gland Cytopathology is a recently proposed scheme from an international group of cytologists with the support of the American Society of Cytopathology and the International Association of Cytopathology that hopes to standardize the reporting of salivary gland FNA. The proposed system uses fairly traditional cytologic categories, such as nondiagnostic, non-neoplastic, atypical, positive for neoplasm (benign or uncertain malignant potential), suspicious for malignancy, and malignant. One addition in the proposed Milan System divides neoplastic aspirates into benign neoplasm and neoplasm of uncertain malignant potential. This nuance indicates acceptance of the importance of determining the presence of neoplasia and the significant overlap between benign and malignant neoplasms that exist in the setting of salivary glands. A recent comprehensive review examining the use of the proposed Milan categories in the literature identified a risk stratification that may be useful to guide clinical management in patients with salivary gland tumors.
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Another recent proposal uses a morphologic patternbased approach, once the findings are sufficient for a neoplastic diagnosis, to stratify ROM, limit differential diagnostic considerations, and guide ancillary testing. 12, 13 Briefly, this pattern-based schema separates basaloid tumors from oncocytoid tumors ( Table 1 , left column). Basaloid tumors are further divided based on the quality of the stroma, such that those neoplasms lacking clearly identifiable and uniformly fibrillary stroma have a higher ROM than those with definitive and abundant fibrillary stroma occupying >75% of the material. On the oncocytoid side, the presence of mucus in the background or tumor cells with granular/vacuolated cytoplasm are associated with a higher ROM. Of note, this pattern-based riskstratification scheme could easily be used to supplement the proposed Milan System. This might be especially useful for salivary tumors categorized as "neoplasm of uncertain malignant potential," for which a broad ROM might be expected. Further separation of such aspirates using pattern-based features of stromal characteristics and background material could narrow the ROM and limit differential diagnostic considerations.
The objective of the current study was to examine the interobserver variability of the proposed pattern-based risk-stratification scheme described by Griffith et al. 12 In addition, the ROM is examined for each of the diagnostic categories to determine whether the results corroborate those of the original proposal. On the basis of these data, the potential to reduce the number of pattern-based categories and simplify this system was also investigated.
MATERIALS AND METHODS

Case Selection
In total, 50 salivary gland aspirates were selected from cases between 2013 and 2015, divided evenly between 2 large academic centers, and examined by 4 cytopathologists from 2 institutions (Emory University and the University of Pittsburgh Medical Center). Slides from salivary gland aspirates during the 2-year period were reviewed (C.C.G. for Emory University and S.E.M. for the University of Pittsburgh Medical Center) to select 25 cases from each institution. Cases with slides that had material representative of the final prospective cytologic diagnosis were selected, and these slides were used for digital scanning. The cases included a variety of diagnoses, from nonneoplastic to benign and malignant neoplasms, of which the malignant cases had confirmatory surgical follow-up. Histologic diagnoses of these cases with available surgical follow-up are detailed in Table 2 . When available, 1 representative slide each of Papanicolaou-stained and Romanowsky-stained smears and 1 hematoxylin and eosin (H&E)-stained cell block section were chosen for digital scanning with an Aperio scanner (Leica Biosystems, Wetzlar, Germany). Thirty-three cases had 1 slide each of a Papanicolaou-stained smear, a Romanowsky-stained smear. and an H&E-stained cell block section; 13 had a Papanicolaou-stained smear and a Romanowsky-stained smear; 3 had a Papanicolaou-stained smear and an H&E-stained cell block section; and a single case had only a Papanicolaou-stained smear. There was a 2-week washout period during which slides were not reviewed until 2 weeks after selection. All cases were randomly coded with an alphanumeric code, and digitally scanned slides were then evaluated independently by all authors using Aperio Imagescope viewer software (Leica Biosystems). Each case was evaluated for adequacy and categorized as nonneoplastic, atypical, neoplastic, or malignant. In cases that were considered at least suspicious for neoplasm, a pattern was assigned using the pattern-based risk-stratification scheme proposed by Griffith et al (Table 1 , left column).
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One author (C.C.G.) was involved in the original development and proposal of this pattern-based scheme, and the other observers reviewed the original proposal article and a summary chart describing the pattern-based classification for those lesions that were deemed at least neoplastic; however, no specific training was given in the recognition of these patterns. To examine the effect of simplification in this proposed pattern-based system, several categories were condensed on secondary analysis (Table 1 , right column). In this simplified scheme, basaloid neoplasms were divided into those with fibrillary stroma (includes an aggregate of PA and basaloid neoplasms with fibrillary stroma) and those with nonfibrillary stroma (includes an aggregate of those neoplasms with hyaline stroma and mixed stroma). Similarly, oncocytoid neoplasms with cystic or other background were condensed into a single group.
Calculation of the Aggregate ROM
Aggregated ROM was calculated for each pattern by scoring each individual classification among the 4 observers as 
Determination of Interobserver Agreement
Because of the small case numbers and the numbers of potential classifications that precluded statistical analysis, interobserver agreement was determined using a scaled scoring scheme, as outlined in Table 3 . This study was meant to determine the interobserver variability of the proposed pattern-based scheme; therefore, only cases in which at least 2 observers classified an aspirate as neoplastic were included for analysis. In total, 4 cases included in this analysis were not considered diagnostic of neoplasm by all authors (ie 2 cases by 1 observer and 2 cases by 2 observers were individually considered non-neoplastic but as at least 2 observers agreed with neoplasia the cases were included in the analysis of interobserver agreement). Table 4 details the aggregated ROMs for the proposed categories. Overall, there was a stratification in the ROM within basaloid neoplasms. Those tumors classified as "PA" and "basaloid neoplasm with fibrillary stroma" (Fig. 1A) had a low ROM at 14.3% (3 of 21 tumors and 2 of 14 tumors, respectively) on surgical follow-up. By comparison, basaloid neoplasms with nonfibrillary stroma (Fig.  1B) had a higher ROM at 83.3% (5 of 6 cases) and 60% (6 of 10 cases) for those classified as having hyaline or mixed/other stroma, respectively. Cases classified as "pleomorphic basaloid neoplasm" also had a high ROM at 75% (3 of 4 cases). Condensation of these patterns into "basaloid neoplasm with fibrillary stroma" (to include "PA" and "basaloid neoplasm with fibrillary stroma"), "basaloid neoplasm with nonfibrillary stroma" (to include "basaloid neoplasm with hyaline stroma" and "basaloid neoplasm with mixed/other stroma"), and "pleomorphic basaloid neoplasm" allows simplification of the proposed scheme and maintains risk stratification, for an ROM of 14.3% (5 of 35 cases), 68.8% (11 of 16 cases), and 75% (3 of 4 cases), respectively.
RESULTS
Aggregated ROMs
Oncocytoid neoplasms also exhibited stratification in the ROM (Table 4) . Cases classified as "WT" had the lowest ROM at 0%, and all 16 such cases were benign on follow-up. The ROM is progressively increased in the Salivary FNA Interobserver Variability/Griffith et al
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other categories when divided by background and cytoplasmic features from 25% (1 of 4 cases) for "oncocytoid neoplasm with cystic background," 40% (2 of 5 cases) for "oncocytoid neoplasm with other background," 80% (24 of 30 cases) for "oncocytoid neoplasm with mucinous background" (Fig. 2) , and 81.3% (13 of 16 cases) for "oncocytoid neoplasm with granular/vacuolated cytoplasm." Cases categorized as "pleomorphic oncocytoid neoplasm" were universally malignant on follow-up (ROM 100%; 17 of 17 cases).
Like the basaloid group, some condensation of these oncocytoid patterns is also possible. "WT" can be maintained as a separate pattern, because the ROM in this study and the prior proposal was 0% (0 of 45 cases), 12 indicating that the diagnosis of WT can be made confidently when suitable diagnostic features are present. Such a category could allow some patients to more easily avoid surgery, depending on the clinical situation. Oncocytoid neoplasms with cystic or other background can be combined into a low-risk oncocytoid neoplasm category and termed Original Article "oncocytoid neoplasm with cystic/other background." The resultant ROM for this group is 33.3% (3 of 9 cases), falling between the lowest risk group of "WT" and higher risk groups of "oncocytoid neoplasm with mucinous background" and "oncocytoid neoplasm with granular/vacuolated cytoplasm."
Interobserver Agreement
Of the 50 cases included in the study, 42 (84%) were considered neoplastic by at least 2 observers and thus were included for the subsequent analysis of interobserver variability. Overall, interobserver agreement was quite good, despite the high number of potential categories in the initial proposal of Griffith et al (Fig. 3A) . By using the scoring detailed in Table 3 , 23.8% (10 of 42 cases) had uniform agreement, 33.3% (14 of 42 cases) had majority agreement, and 11.9% (5 of 42 cases) had divided agreement. More than one-half of cases (57.1%; 24 of 42) had uniform or majority agreement, such that the ROM and differential diagnostic considerations would be similar despite minor differences in final classification. Only 21.4% (9 of 42 cases) and 9.5% (4 of 42 cases) had minimal or no agreement, respectively. When the aforementioned, more simplified classification scheme was applied, there was an increase in the number of cases with uniform agreement and a decrease in cases with no agreement (Fig. 3B) . With this simplified scheme, one-half (n 5 7) of the cases previously scored as having majority agreement resulted in uniform agreement, such that 40.5% (17 of 42) aspirates had uniform agreement. All 7 of these cases with a shift in agreement to uniform were because of the condensation of basaloid neoplasms into those with fibrillary or nonfibrillary stroma. The proportion of cases with uniform or majority agreement, however, remained the same (57.1%).
With the condensation of diagnostic categories, only a single case improved from no agreement to minimal agreement. This was a basal cell adenoma that demonstrated improved agreement because of the condensed basaloid categories. In addition, a single case was raised from minimal agreement to divided agreement. Again, this improvement was because of condensation of basaloid categories and was a case of PA. Of note, 3 cases diagnosed as PA on surgical follow-up in our study that had low interobserver agreement as a result of categorization of fibrillary stroma as background mucus in an oncocytoid neoplasm (ie, 1 observer classified an aspirate from a PA as an oncocytoid neoplasm with mucinous background, and the others agreed on the designation of PA) (Fig. 4) .
DISCUSSION
In the current study, we examine the interobserver variability of the proposed pattern-based risk-stratification scheme of Griffith et al using digital slides from 2 institutions. We also confirm the ability of this pattern-based approach to stratify aspirates into groups with different ROM, which is similar to that of the initial proposal. 12 
Risk Stratification With This Pattern-Based Scheme Is Confirmed
Because of the small number of cases included in the current study, an aggregated ROM was calculated for each categorization made by individual observers. By using these aggregated ROMs, the current study demonstrates a riskstratification profile similar to that reported in the original proposal, and some categories had nearly identical ROMs. 12 Specifically, pattern categories with nearly identical ROM include basaloid neoplasm with fibrillary stroma (14.3% compared with 15.4%, respectively), basaloid neoplasm with mixed/hyaline stroma (60% in both studies), WT (0% in both studies), oncocytoid neoplasm with mucinous background (80% in both studies), oncocytoid neoplasm with granular/vacuolated cytoplasm (81.3% compared with 84.6%, respectively), and pleomorphic oncocytoid neoplasm (100% in both studies). Several pattern categories had considerably different ROMs in the current study compared with the prior publication, including basaloid neoplasm with hyaline stroma (83.3% compared with 42.9%, respectively) and oncocytoid neoplasm with other background (40% compared with 4%, respectively). Some of this difference may be attributed to the small number of cases included in these pattern categories, resulting in greater fluctuations in ROM between studies. This fluctuation in the ROM for these categories also prompted the condensation of these categories to simplify the scheme, which could resolve some of these differences.
There are several limitations in the ROM calculations presented in this study that deserve discussion. The ROMs that were calculated in this study as in the initial proposal are biased because of the selection of a subset of salivary gland tumor cytology cases, and the actual ROMs for these different pattern-based categories would likely be lower in a prospective study or in a series that included all salivary AdCC indicates adenoid cystic carcinoma; BCA, basal cell adenoma; BCACA, basal cell adenocarcinoma; EMCA, epithelial myoepithelial carcinoma; Infl, inflammatory lesion; MEC, mucoepidermoid carcinoma; PA, pleomorphic adenoma; SC, secretory carcinoma; SDC, salivary duct carcinoma; SDCexPA, salivary duct carcinoma ex pleomorphic adenoma; SqCC, squamous cell carcinoma; Unk, unknown diagnosis; WT, Warthin tumor. Note that (11) indicates cases in which there was no histologic follow-up but the clinical history, original sign out, and consensus diagnoses from the current review supported designation as pleomorphic adenoma or an inflammatory lesion. gland aspirates over a given period. The lack of surgical follow-up in some cases could also introduce bias into the ROM calculations. Finally, the small number of cases included in this study may not reflect the risk in a larger series, although it should be noted that the current series had similar ROMs, as discussed above. Despite these limitations, the findings do suggest that the different patterns have the potential to result in risk stratification for salivary gland tumors, as demonstrated in the initial larger study based on histologic follow-up. 12 Additional studies will be needed to more accurately define the ROM in actual practice.
The current study demonstrates that the proposed pattern-based risk-stratification scheme proposed by Griffith et al for the classification of salivary gland aspirates has good interobserver agreement. These results were attained despite the fact that this pattern-based system incorporates more categories than most traditional risk-categorization schemes in cytopathology, such as the Bethesda systems for reporting cervicovaginal and thyroid cytologic samples. The reasons for this overall good interobserver variability are likely because this proposed system is based on simple morphologic distinguishing features, many of which are already considered by practicing cytopathologists when presented with a salivary gland tumor aspirate.
The ability to identify a salivary gland aspirate as a basaloid neoplasm offers a general differential diagnosis that many experienced cytopathologists recognize. By incorporating stromal characteristics of basaloid neoplasms in the proposed pattern-based approach, differential diagnostic considerations are refined, and the ROM for these aspirates is stratified, as demonstrated in the original scheme proposal. 12 In contrast to the basaloid group, the concept of an oncocytoid neoplasm in aspiration cytology of the salivary glands is not as well established. However, the ability to add risk stratification and limit differential diagnostic considerations based on background, cytoplasm, and/or cytonuclear grade in the setting of such oncocytoid neoplasms is confirmed by this study. Like basaloid neoplasms, the features used to risk stratify oncocytoid neoplasms include well known cytomorphologic features. For example, the presence of granular cytoplasm is a well established feature of AciCC. Although secretory carcinoma classically displays more vacuolated cytoplasm, similarities between AciCC and secretory carcinoma make the distinction of these 2 entities difficult on aspiration cytology. The categorization of aspirates as oncocytoid neoplasm with granular/vacuolated cytoplasm is designed to aid in the recognition of these 2 cytologically bland malignancies and highlights the significant ROM associated with this pattern.
Perhaps one of the more difficult differential diagnoses in salivary gland cytopathology is the distinction of WT with mucinous metaplasia from a low-grade to intermediate-grade MEC. Aspirates from both of these entities exhibit low-grade oncocytoid epithelial cells with or without mucus cells and frequently have a prominent mucinous background. Although a prior study demonstrated that the presence of mucus was not a significant distinguishing feature between WT and MEC, 14 our findings suggest that the presence of prominent mucus indicates a higher ROM on histologic follow-up. Whereas some cases classified as oncocytoid neoplasm with mucinous background were benign on excision (mostly WT), those findings demonstrate the importance of this categorization to highlight the significant ROM associated with this pattern.
In the absence of a risk-stratification scheme, such an aspirate would often be diagnosed descriptively with a differential diagnosis including WT and MEC; however, the significant ROM may not be communicated effectively to the treating physician. In such cases, categorization as positive for an oncocytoid neoplasm with mucinous background could be important to prompt surgical excision.
Simplification of the Scheme With Condensation of Similar Categories Preserves Risk Stratification and Offers Some Improvements in Interobserver Variability
Although there was good agreement with the initially proposed pattern-based system, we believed that there was room for simplification through condensation of categories with overlapping morphologic features, differential diagnostic considerations, and ROM. Hence, the number of categories was reduced, and, not unexpectedly, the overall interobserver variability was improved. Basaloid neoplasms with hyaline and mixed/other stroma were conveniently condensed into a single category of basaloid neoplasm with nonfibrillary stroma. This new grouping has a high ROM, and the distinction between subtly different forms of stroma was 1 source of interobserver disagreement. Almost all of the improvements in agreement were because of condensation of the basaloid neoplasm categories (Table 4) . Less condensation of oncocytoid groups was possible because these tumors exhibit more divergent morphologic features. In addition, the condensation of oncocytoid neoplasm with cystic background or other background into a single category had minimal effect in improving interobserver agreement. Further improvements in interobserver variability may be possible with a training set before evaluating salivary gland aspirates.
Traditional Pitfalls in Salivary Gland Aspiration Cytology Still Must Be Avoided
There are several traditional pitfalls in salivary gland cytology that still must be remembered for those attempting to use this pattern-based risk-stratification scheme or another proposed scheme. For example, 1 of the difficulties in the diagnosis of AciCC is the potential to misinterpret neoplastic acinar cells as normal non-neoplastic acinar tissue. Features that are useful in recognizing AciCC are the finding of exclusively acinar cells without normal architectural clustering and a lack of ductal cells, cells with reduced cohesion, and cells with fragile cytoplasm indicated by naked nuclei. 15 Difficulty in differentiating the fibrillary stroma of PA from mucus can also cause diagnostic confusion between aspirates from PA and MEC. In this setting, histiocytes within mucus can appear to be myoepithelial cells in myxoid stroma, and vice versa. Three cases in our study that had low interobserver agreement were a result of this pitfall. In each of these 3 cases, a single observer classified an aspirate from a PA as an oncocytoid neoplasm with mucinous background, whereas the other observers agreed on the designation of PA. This potential pitfall may have been accentuated by the use of only limited numbers of representative slides and the use of digitally scanned slides with limited resolution.
Limitations
Nearly one-third of cases in this series that had no to minimal agreement (12-13 of 42 cases; 28.6%-31%), which raise questions about the clinical utility of the proposed classification scheme. However, currently, there is no system for the classification of salivary gland tumor aspiration cytology, and it is generally accepted that this is a challenging area because of the morphologic overlap observed in these tumors, spanning both benign and malignant behavior. Even in well established and accepted standard cytology categorization systems, such as The Bethesda System for Reporting Cervical Cytology, there is significant variability, especially in the use of atypical cells of undetermined significance (ASCUS), with 1 study indicating that, of 1473 monolayer cytology specimens originally designated ASCUS, only 633 (43.0%) were interpreted as ASCUS on second review. 16 Other categories demonstrated agreement on second review of 77.6% for negative cases, 68% for low-grade squamous intraepithelial lesions, and 47.1% for high-grade squamous intraepithelial lesions and greater. Interobserver variability has also been demonstrated in thyroid cytopathology by various studies. 17, 18 Although the results from those previous studies are not directly comparable to the results from our study, they highlight the inherent interobserver variability that can be expected in categorization schemes for cytologic samples. Given the inherent interobserver variability of classification schemes, the complexity of salivary gland tumor cytology, and the early phase of this proposed scheme, this poor agreement on these cases should not preclude further work to develop a standardized system for reporting salivary gland cytology. Continued refinement of this patternbased system and increased experience might further improve interobserver agreement and enhance the clinical potential of such a system. Some of the limitations in the current study may also have contributed to these cases with poor interobserver variability, and these include the lack of specific training and/ or experience with this specific pattern-based risk-stratification scheme. However, as users become more familiar with the system, agreement among observers may improve. We also have not examined the source of the lack of agreement in these specific cases; however, given the fairly even distribution of histologic diagnoses across the areas of agreement, as observed in Figure 3 , it may be related more to the quality or cellularity of the available slides than to the specific diagnosis or pattern.
Conclusion
This study adds further support to the use of a patternbased risk-stratification scheme in the classification of salivary gland tumors. The ability to stratify the ROM using the proposed patterns confirms similar results of the initial proposal by Griffith and colleagues. In addition, despite the complexity of the proposed scheme, we demonstrated that interobserver variability is good and can be improved with condensation of some of these categories while still preserving the desired risk stratification and differential diagnoses. Further study is planned to examine a more realistic prediction of ROM for these various patterns in a more systematic examination of salivary gland aspirates. This pattern and risk-based classification scheme has potential to be used in conjunction with the forthcoming Milan System for Reporting Salivary Gland Cytopathology. The proposed Milan System could serve as the primary diagnostic categorization (eg, positive for neoplasm of uncertain malignant potential), with this pattern-based scheme serving as a secondary or free-text diagnosis (eg, basaloid neoplasm with nonfibrillary stroma). By clarifying the pattern observed in the aspirate, a more granular impression of the ROM can be given and thus can be more helpful in determining the management for patients with salivary gland tumors, akin to The Bethesda System for Reporting Thyroid Cytology.
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